TA
BMY icon

TCG Advisors’s Bristol-Myers Squibb BMY Stock Holding History

TCG Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-18,832
Closed -$1.11M – 23
2020
Q2 		$1.11M Buy
18,832
+2,658
+16% +$159K 0.61% 54
2020
Q1 		$902K Buy
16,174
+22
+0.1% +$1.34K 0.74% 47
2019
Q4 		$1.04M Sell
16,152
-272
-2% -$15.6K 0.62% 51
2019
Q3 		$833K Buy
16,424
+2,815
+21% +$132K 0.6% 60
2019
Q2 		$635K Buy
13,609
+1,656
+14% +$77.1K 0.58% 55
2019
Q1 		$570K Buy
11,953
+1,502
+14% +$74.8K 0.52% 58
2018
Q4 		$543K Buy
+10,451
New +$562K 0.55% 53

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

TCG Advisors's BMY Position: Q3 2020 in Review

TCG Advisors sold out of Bristol-Myers Squibb (BMY) in Q3 2020, closing a stake of 18,832 shares — an estimated $1.11M sold.

TCG Advisors first reported a position in BMY in Q4 2018 and held it in 7 quarters. The position peaked at $1.11M in Q2 2020. 2,215 funds tracked by Wall St. Rank hold BMY as of Q3 2020.

  • TCG Advisors reported no remaining Bristol-Myers Squibb position as of Q3 2020 after selling out during the quarter.
  • TCG Advisors sold 18,832 Bristol-Myers Squibb shares in Q3 2020, an estimated $1.11M.
  • TCG Advisors first reported a position in Bristol-Myers Squibb in Q4 2018 and held it in 7 quarters.
  • TCG Advisors's Bristol-Myers Squibb position peaked at $1.11M in Q2 2020.
  • 2,215 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.

Based on TCG Advisors's 13F filing for Q3 2020, filed 13 Nov 2020.